A study conducted in humans submitted to abdominal or cardiac surgery in the HC of the UFTM. Thoracic surgery
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age greater than 18 years; submitted to abdominal surgery (elective or complicated cholelithiasis, choledocholithiasis, obstructive jaundice, acute pacritatitis, acute cholestasis) and cardiac surgery that are hospitalized at the Hospital de Clínicas of UFTM; With post operative pain complaint; Ability to respond to assessment; Absence of provisional or definitive pacemaker; Sign the TCLE.
Exclusion criteria
Exclusion criteria: • Dehiscence or infection in the surgical incision with exposure of the injured skin; Tumors; New surgery during the intervention or death period; Supra renal disease, use of corticosteroids or steroid anti-inflammatory drugs that alter or influence the dosage of cortisol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| As a primary endpoint or direct result, patients' pain relief in the postoperative period of cardiac and digestive surgeries is expected after the application of TENS. | — |
Secondary
| Measure | Time frame |
|---|---|
| And as a side effect it is expected that it will promote a reduction in analgesic consumption, helping to reduce symptoms such as nausea and emesis, as well as an increase in forced vital capacity and pulmonary tidal volume, increased respiratory muscle strength due to the facilitated physiotherapeutic treatment by the analgesic effect. A secondary effect on the immune system is also expected with the reduction of cytokines (IL1, IL6, IL10 and TNF) and cortisol. | — |
Countries
Brazil
Contacts
Universidade Federal do Triângulo Mineiro